Organon & Co

16
4
NYSE:OGN (USA)   Ordinary Shares
$ 17.45 -0.83 (-4.54%) 10:08 PM EST
Enterprise V:
$ 12.53B
Volume:
2.71M
Avg Vol (2M):
2.35M
Also Trade In:
Volume:
2.71M
Avg Vol (2M):
2.35M

Business Description

Organon & Co
NAICS : 325412 SIC : 2834
ISIN : US68622V1061

Share Class Description:

OGN: Ordinary Shares
Description
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
Name Current Vs Industry Vs History
Cash-To-Debt 0.08
Equity-to-Asset -0.01
Debt-to-Equity -125.14
Debt-to-EBITDA 6.1
Interest Coverage 2.52
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.28
Distress
Grey
Safe
Beneish M-Score -2.16
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 27.75
9-Day RSI 36.61
14-Day RSI 42.59
6-1 Month Momentum % 9.8
12-1 Month Momentum % -22.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.54
Quick Ratio 1.09
Cash Ratio 0.24
Days Inventory 169.05
Days Sales Outstanding 93.06
Days Payable 163.24

Financials (Next Earnings Date:2024-05-03 Est.)

OGN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:OGN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Organon & Co Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 6,263
EPS (TTM) ($) 4
Beta 0
Volatility % 54.57
14-Day RSI 42.59
14-Day ATR ($) 0.513782
20-Day SMA ($) 18.109
12-1 Month Momentum % -22.62
52-Week Range ($) 10.835 - 24.79
Shares Outstanding (Mil) 255.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Organon & Co Filings

Filing Date Document Date Form
No Filing Data

Organon & Co Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Organon & Co Frequently Asked Questions

What is Organon & Co(OGN)'s stock price today?
The current price of OGN is $17.45. The 52 week high of OGN is $24.79 and 52 week low is $10.84.
When is next earnings date of Organon & Co(OGN)?
The next earnings date of Organon & Co(OGN) is 2024-05-03 Est..
Does Organon & Co(OGN) pay dividends? If so, how much?
The  Dividend Yield %  of Organon & Co(OGN) is 6.42% (As of Today), Highest Dividend Payout Ratio of Organon & Co(OGN) was 0.35. The lowest was 0.1. And the median was 0.27. The  Forward Dividend Yield % of Organon & Co(OGN) is 6.42%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1